Electrocardiographic criteria and outcome in patients with arrhythmgenic right ventricular cardiomyopathy. Re: Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: Implications for arrhythmic risk stratification

2014 ◽  
Vol 174 (3) ◽  
pp. 723
Author(s):  
Stefan Peters
Keyword(s):  
Risk Stratification ◽  
Right Ventricular ◽  
Arrhythmogenic Right Ventricular Cardiomyopathy ◽  
Ventricular Cardiomyopathy ◽  
Scar Size

scholarly journals Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Risk Stratification and Therapy

2008 ◽  
Vol 50 (4) ◽  
pp. 282-293 ◽  
Author(s):  
Gianfranco Buja ◽  
N.A. Mark Estes ◽  
Thomas Wichter ◽  
Domenico Corrado ◽  
Frank Marcus ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Right Ventricular ◽  
Arrhythmogenic Right Ventricular Cardiomyopathy ◽  
Ventricular Cardiomyopathy

scholarly journals Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy

2021 ◽  
Vol 10 (1) ◽  
pp. 26-32
Author(s):  
Ryan Wallace ◽  
Hugh Calkins
Keyword(s):  
Ventricular Arrhythmia ◽  
Risk Stratification ◽  
Right Ventricular ◽  
Arrhythmogenic Right Ventricular Cardiomyopathy ◽  
Arrhythmogenic Right Ventricular Dysplasia ◽  
Young Population ◽  
Arrhythmogenic Cardiomyopathy ◽  
Ventricular Cardiomyopathy ◽  
Increased Risk ◽  
Fibrofatty Tissue

Arrhythmogenic right ventricular cardiomyopathy (ARVC), also called arrhythmogenic right ventricular dysplasia or arrhythmogenic cardiomyopathy, is a genetic disease characterised by progressive myocyte loss with replacement by fibrofatty tissue. This structural change leads to the prominent features of ARVC of ventricular arrhythmia and increased risk for sudden cardiac death (SCD). Emphasis should be placed on determining and stratifying the patient’s risk of ventricular arrhythmia and SCD. ICDs should be used to treat the former and prevent the latter, but ICDs are not benign interventions. ICDs come with their own complications in this overall young population of patients. This article reviews the literature regarding the factors that contribute to the assessment of risk stratification in ARVC patients.

Risk stratification in arrhythmogenic right ventricular cardiomyopathy

2013 ◽  
Vol 24 (4) ◽  
pp. 202-208 ◽  
Author(s):  
M. Silvano ◽  
D. Corrado ◽  
J. Köbe ◽  
G. Mönnig ◽  
C. Basso ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Right Ventricular ◽  
Arrhythmogenic Right Ventricular Cardiomyopathy ◽  
Ventricular Cardiomyopathy
Sign in / Sign up

Export Citation Format

Share Document